Mobile phone radiation and brain tumors

Share This Post

The California Department of Public Health issued guidelines on cell phone radiation and how to reduce exposure.

According to the CBS report, although there is no conclusive medical evidence, some studies have shown that mobile phone use may be related to brain tumors , headaches, low sperm count, memory, hearing and sleep problems.

Dr. Smith of the California Department of Public Health told CBS, “A lot of people are worried that high-frequency use of mobile phones is harmful to health and whether it is safe to use mobile phones.”

Dr. Smith said that when you sleep, your phone is at least one arm away from your body. Also, don’t put your phone in your pocket, put it in your wallet, or carry it with you.

The new guide also recommends: reduce the use of mobile phones when the signal is weak; use less mobile phones to transmit audio or video, download or upload large files; do not put the mobile phone on the bed at night; take off the headset without making a call.

However, despite the release of new guidelines, the government did not say that mobile phones are dangerous.

Dr. Smith stated that our position is that science is constantly evolving.

According to a CBS News report, the main reason for national officials to publish this guideline is that new data shows that cell phone usage has reached its highest level in history, with 95% of Americans using cell phones.

The International Agency for Research on Cancer of the World Health Organization has classified the radiation emitted by mobile phones as “probably carcinogenic.

The results of some studies published last year by the National Toxicology Program of the United States show that radio frequency radiation poses a higher risk of two types of cancer in male rats. More importantly, this study found that the higher the radiation dose, the stronger the response.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy